Meitheal Pharmaceuticals Inc
Meitheal Pharmaceuticals Inc appears in FDA public data with 3 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0340-2026, Class II) was initiated on February 9, 2026.
Summary
- Total Recalls
- 3 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0340-2026 | Class II | Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meithe | February 9, 2026 |
| D-0801-2021 | Class III | Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharma | September 3, 2021 |
| D-0286-2021 | Class I | Cisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-0 | January 27, 2021 |